lazabemide has been researched along with clorgyline in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almos, T; Edmondson, DE; Massari, ME; Rojas, RJ; Scott, R | 1 |
| Kang, MG; Kim, H; Lee, HW; Oh, SR; Park, D; Ryu, HW | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Kim, SH; Lee, HW; Oh, SR; Park, D; Ryu, HW | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Oh, SR; Park, D; Ryu, HW | 1 |
| Annie Rilda, PR; Baek, SC; Grace Thomas Parambi, D; Inasu, ST; Joy, M; Kim, H; Kumar Krishnan, G; Lohidakshan, KK; Mathew, B; Mathew, GE; Nithyamol, P; Pil Lee, J; Randev, RV; Vijayan, V | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Lee, JP; Oh, SR; Park, CM; Park, D; Park, JE; Ryu, HW | 1 |
| Cesura, AM; Da Prada, M; Kettler, R; Richards, JG | 1 |
| Akaike, N; Himori, N; Suzuki, T; Tanaka, Y; Ueno, K | 1 |
| Abercrombie, ED; Wachtel, SR | 1 |
| Fitzgerald, DH; Tipton, KF | 1 |
| Inoue, T; Izumi, T; Kitaichi, Y; Koyama, T; Nakagawa, S | 1 |
11 other study(ies) available for lazabemide and clorgyline
| Article | Year |
|---|---|
Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
Topics: Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Small Molecule Libraries; Thermodynamics | 2015 |
Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
Topics: Anthraquinones; Cell Line; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2017 |
Selective inhibition of monoamine oxidase A by hispidol.
Topics: Benzofurans; Binding Sites; Clorgyline; Flavonoids; Humans; Inhibitory Concentration 50; Kinetics; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazolidinones; Picolinic Acids | 2018 |
Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
Topics: Benzophenanthridines; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2018 |
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors.
Topics: | 2018 |
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Topics: Acetylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Enzyme Assays; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Structure-Activity Relationship | 2019 |
Reversible, enzyme-activated monoamine oxidase inhibitors: new advances.
Topics: Animals; Benzamides; Brain; Clorgyline; Humans; In Vitro Techniques; Male; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Picolinic Acids; Piperidines; Rats; Selegiline | 1988 |
MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Ischemia; Clorgyline; Dopamine; Hydroxyl Radical; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase Inhibitors; Picolinic Acids; Reperfusion | 1995 |
L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Levodopa; Male; Monoamine Oxidase Inhibitors; Nerve Endings; Oxidopamine; Picolinic Acids; Rats; Rats, Sprague-Dawley; Selegiline | 1994 |
Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).
Topics: Amine Oxidase (Copper-Containing); Animals; Brain; Clorgyline; Dopamine; Female; Heart; Kinetics; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Picolinic Acids; Rats; Rats, Sprague-Dawley; Serotonin; Subcellular Fractions; Tranylcypromine | 2002 |
Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Clorgyline; Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Fear; Lithium Carbonate; Male; Models, Animal; Monoamine Oxidase Inhibitors; Motor Activity; Norepinephrine; Picolinic Acids; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin | 2006 |